WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2005009367) TREATMENT OF DISEASES WITH KINASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2005/009367 International Application No.: PCT/US2004/023325
Publication Date: 03.02.2005 International Filing Date: 19.07.2004
IPC:
A01N 55/02 (2006.01) ,A61K 31/50 (2006.01) ,A61K 31/54 (2006.01)
A HUMAN NECESSITIES
01
AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
N
PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
55
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
02
containing metal atoms
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
50
Pyridazines; Hydrogenated pyridazines
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
54
having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame
Applicants: BIGGS III, William, H.[US/US]; US (UsOnly)
CARTER, Todd[US/US]; US (UsOnly)
FABIAN, Miles, A.[US/US]; US (UsOnly)
LOCKHART, David, J.[US/US]; US (UsOnly)
ZARRINKAR, Patrick, Parvis[US/US]; US (UsOnly)
TREIBER, Daniel, Kelly[US/US]; US (UsOnly)
EDEEN, Phillip[US/US]; US (UsOnly)
AMBIT BIOSCIENCES CORPORATION[US/US]; 4215 Sorrento Valley Boulevard San Diego, CA 92121, US (AllExceptUS)
Inventors: BIGGS III, William, H.; US
CARTER, Todd; US
FABIAN, Miles, A.; US
LOCKHART, David, J.; US
ZARRINKAR, Patrick, Parvis; US
TREIBER, Daniel, Kelly; US
EDEEN, Phillip; US
Agent: ROCHE, Anie, K.; Wilson Sonsini Goodrich & Rosati 650 Page Mill Road Palo Alto, CA 94306-1050, US
Priority Data:
60/488,51317.07.2003US
Title (EN) TREATMENT OF DISEASES WITH KINASE INHIBITORS
(FR) TRAITEMENT DE MALADIES AU MOYEN D'INHIBITEURS DE KINASE
Abstract:
(EN) The invention is directed to the identification and use of additional targets of BIRB 796, imatinib mesylate, and BAY 43-9006. The new targets of BIRB 796, imatinib mesylate, and BAY 43-9006 can be used to screen for suitable therapeutic compounds. Also, novel therapeutic and prophylactic uses for BIRB 796, imatinib mesylate, and BAY 43-9006 are disclosed herein.
(FR) L'invention concerne l'identification et l'utilisation de cibles supplémentaires de BIRB 796, de mésylate d'imatinib et de BAY 43-9006. Ces nouvelles cibles de BIRB 796, de mésylate d'imatinib et de BAY 43-9006 peuvent être employées pour le criblage de composés thérapeutiques adaptés. L'invention concerne également de nouvelles utilisations thérapeutiques et prophylactiques de BIRB 796, de mésylate d'imatinib et de BAY 43-9006.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)